Franklin Resources Inc Bridge Bio Pharma, Inc. Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 6,900 shares of BBIO stock, worth $163,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,900

Previous 6,900 -0.0%

Holding current value

$163,668

Previous $174,000 0.57%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $54,073 - $72,975	2,351 Added 51.68%	6,900 $174,000
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $124,415 - $184,007	4,549 New	4,549 $140,000
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $2.11 Million - $4.92 Million	-286,837 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.38 - $53.41 $17,126 - $80,382	1,505 Added 0.53%	286,837 $4.78 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $86,334 - $118,330	1,842 Added 0.65%	285,332 $13.4 Million
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $28,300 - $38,933	-609 Reduced 0.21%	283,490 $17.3 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $1,664 - $2,170	30 Added 0.01%	284,099 $17.5 Million
Q4 2020 Feb 10, 2021	BUY	$38.38 - $71.11 $22,413 - $41,528	584 Added 0.21%	284,069 $20.2 Million
Q3 2020 Nov 12, 2020	BUY	$27.2 - $42.19 $5,032 - $7,805	185 Added 0.07%	283,485 $10.6 Million
Q4 2019 Feb 12, 2020	SELL	$17.96 - $46.63 $1.2 Million - $3.11 Million	-66,700 Reduced 19.06%	283,300 $9.93 Million
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $9.44 Million - $9.64 Million	350,000 New	350,000 $9.44 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.52B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Bridge Bio Pharma, Inc. Transaction History